Skip to content

Medical-device intelligence

LFW: Fluorescence Polarization Immunoassay, Tobramycin

FDA product code LFW: Fluorescence Polarization Immunoassay, Tobramycin. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LFW
FDA device name
Fluorescence Polarization Immunoassay, Tobramycin
Device class
2
Regulation number
862.3900
Medical specialty
Clinical Toxicology
Review panel
TX

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

10 clearance records and 2 recall records in the covered releases, across 9 source company names and 1 product codes. Dated history runs from May 31, 1984 to Oct 16, 2013.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
LFW · Fluorescence Polarization Immunoassay, Tobramycin102

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

12 matching records
Device / recordCompany in FDA recordSourceSource date
Thermo Fisher Scientific/Microgenics brand CEDIA Tobramycin II Assay, Catalog Number 100018, Product is manufactured and distributed by Microgen…Z-0513-2014 · LFWMicrogenics CorpRecallDec 16, 2013FDA classification date
Roche brand CEDIA Tobramycin II Reagent, Catalog # 1815385, Material # 11815385216.Z-0574-06 · LFWRoche Diagnostics Corp.RecallFeb 28, 2006FDA classification date
ROCHE COBAS-FP REAGENTS FOR TOBRAMYCINK964670 · LFWRoche Diagnostic Systems, Inc.510(k)Feb 4, 1997FDA decision date
TOBRAMYCIN FPIA REAGENT SET AND CALIBRATORK944371 · LFWSigma Diagnostics, Inc.510(k)Nov 10, 1994FDA decision date
AXSYM TOBRAMYCINK941614 · LFWAbbott Laboratories510(k)Aug 18, 1994FDA decision date
CEDIA(R) TOBRAMYCIN ASSAYK912143 · LFWMicrogenics Corp.510(k)Jul 26, 1991FDA decision date
MODIFIED ACCUFLUOR TOBRAMYCIN REAGENT & CALIBRATORK900707 · LFWInnotron of Oregon, Inc.510(k)Apr 20, 1990FDA decision date
FPR TOBRAMYCIN KITK894531 · LFWColony Laboratories, Inc.510(k)Sep 1, 1989FDA decision date
INNOTRON INNOFLUOR TOBRAMYCIN REAGENT SETK872562 · LFWInnotron of Oregon, Inc.510(k)Aug 17, 1987FDA decision date
TOBRAMYCIN KIT(FPIA)FLUORESCENCE POLARIZATION IMMUK854392 · LFWWindsor Laboratories, Inc.510(k)Dec 5, 1985FDA decision date
COBAS REAGENTS FOR TOBRAMYCIN & CALIBRAK843828 · LFWRoche Diagnostic Systems, Inc.510(k)Feb 1, 1985FDA decision date
INNOFLOUR TOBRAMYCINK841866 · LFWInnotron Diagnostics510(k)May 31, 1984FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗